435 related articles for article (PubMed ID: 20370586)
21. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
Bianchi DW; Avent ND; Costa JM; van der Schoot CE
Obstet Gynecol; 2005 Oct; 106(4):841-4. PubMed ID: 16199645
[TBL] [Abstract][Full Text] [Related]
23. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
[TBL] [Abstract][Full Text] [Related]
24. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
Daniels G; Finning K; Martin P; Soothill P
Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
[TBL] [Abstract][Full Text] [Related]
25. [Rh system genotyping in amniotic fluid].
Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A
Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629
[TBL] [Abstract][Full Text] [Related]
26. Prenatal determination of fetal RhD type by DNA amplification.
Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
[TBL] [Abstract][Full Text] [Related]
27. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
Lo YM
Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
[TBL] [Abstract][Full Text] [Related]
29. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive prenatal diagnosis and determination of fetal Rh status.
van der Schoot CE; Hahn S; Chitty LS
Semin Fetal Neonatal Med; 2008 Apr; 13(2):63-8. PubMed ID: 18249590
[TBL] [Abstract][Full Text] [Related]
31. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
32. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
33. Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study.
Benachi A; Delahaye S; Leticee N; Jouannic JM; Ville Y; Costa JM
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):28-32. PubMed ID: 22386678
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.
Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A
Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive determination of fetal rh blood group, D antigen status by cell-free DNA analysis in maternal plasma: experience in a Brazilian population.
Chinen PA; Nardozza LM; Martinhago CD; Camano L; Daher S; Pares DB; Minett T; Araujo Júnior E; Moron AF
Am J Perinatol; 2010 Nov; 27(10):759-62. PubMed ID: 20408112
[TBL] [Abstract][Full Text] [Related]
36. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
[TBL] [Abstract][Full Text] [Related]
37. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.
Finning K; Martin P; Summers J; Daniels G
Transfusion; 2007 Nov; 47(11):2126-33. PubMed ID: 17958542
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive fetal RhCE genotyping from maternal blood.
Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
[TBL] [Abstract][Full Text] [Related]
39. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
